Bioactive lipids and rheumatoid arthritis

November 2, 2017 by Leigh Macmillan, Vanderbilt University

Sphingolipids – long-chain fatty acid molecules found in cell membranes – are broken down by sphingomyelinase enzymes into bioactive products such as ceramide. Growing evidence suggests roles for sphingolipid metabolites in the pathogenesis of rheumatoid arthritis (RA), a chronic inflammatory disease affecting joints.

Leslie Crofford, M.D., and colleagues determined the activity of secretory sphingomyelinase (S-SMase) in patients with RA compared to control subjects, and they examined relationships between S-SMase activity and quality of life and other RA disease measurements.

Using clinical data and archived serum samples from 33 patients with RA and 17 matched control subjects, the investigators found that mean serum S-SMase activity was 1.4-fold higher in patients with RA. S-SMase activity correlated with P-selectin, a biomarker of inflammation, but not with other RA disease measurements.

The findings, reported in the journal Clinical Rheumatology, demonstrate that S-SMase activity is higher among patients compared to controls and support conducting studies to understand the biologic roles of S-SMase in rheumatoid arthritis.

Explore further: Rheumatoid arthritis linked to an increased risk of COPD

More information: Beatriz Y. Hanaoka et al. Secretory sphingomyelinase (S-SMase) activity is elevated in patients with rheumatoid arthritis, Clinical Rheumatology (2017). DOI: 10.1007/s10067-017-3824-1

Related Stories

Rheumatoid arthritis linked to an increased risk of COPD

October 19, 2017
New research suggests that rheumatoid arthritis may increase the risk of developing chronic obstructive pulmonary disease (COPD). The findings, which appear in Arthritis Care & Research, indicate that greater vigilance may ...

Ultrasound IDs disease activity in rheumatoid arthritis

February 15, 2017
(HealthDay)—A 12-joint ultrasound (US) evaluation is relevant in determining disease activity in rheumatoid arthritis patients, according to a study published online Feb. 9 in the International Journal of Rheumatic Diseases.

Pedometers increase activity and decrease fatigue in rheumatoid arthritis patients

April 5, 2017
Providing pedometers, with and without providing step targets, to individuals with rheumatoid arthritis increased activity levels and decreased fatigue in a recent study.

Non-TNF biologic beats second anti-TNF in rheumatoid arthritis

September 21, 2016
(HealthDay)—A non-tumor necrosis factor (TNF)-targeted biologic is more effective than a second anti-TNF drug for treatment of rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug, according ...

Scientists discover new mechanism that leads to inflammation in rheumatoid arthritis

March 2, 2017
New research findings published in the Journal of Leukocyte Biology, suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients. ...

New oral treatment option for rheumatoid arthritis

June 19, 2017
Patients suffering from rheumatoid arthritis are treated for around six months with the standard anti-rheumatic agent methotrexate, to which many patients respond very well. However, if they do not respond and no remission ...

Recommended for you

How environmental pollutants and genetics work together in rheumatoid arthritis

April 19, 2018
It has been known for more than three decades that individuals with a particular version of a gene—human leukocyte antigen (HLA)—have an increased risk for rheumatoid arthritis.

The bugs in your gut could make you weak in the knees

April 19, 2018
Bacteria in the gut, known as the gut microbiome, could be the culprit behind arthritis and joint pain that plagues people who are obese, according to a new study published today in JCI Insight.

Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain

April 11, 2018
Osteoarthritis is one of the most common causes of chronic pain in the world. More than 30 million people in the United States alone suffer from osteoarthritis, or OA, which can affect any moveable joint of the body, including ...

Flare-responsive hydrogel developed to treat arthritis

April 3, 2018
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms—can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic ...

Drug compound shows promise against rheumatoid arthritis

March 28, 2018
Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.

Chromosomal loop signatures could identify poor drug response in arthritis

March 28, 2018
Chromosomal loop signatures found in blood samples obtained in early rheumatoid arthritis could identify patients that will not respond adequately to 'anchor' treatment drug methotrexate.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (2) Nov 05, 2017
Face grease contains 735 different "bioactive" ffa's/esters/alcohols/cholesterols. Hypothesis: RA is pheromonal. Therefore, chemicals which resemble pheromones will have effects on the course of the disease. Duh.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.